Loading…

In Vitro Models of Angiogenesis

Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex...

Full description

Saved in:
Bibliographic Details
Published in:World journal of surgery 2007-04, Vol.31 (4), p.654-663
Main Authors: Ucuzian, Areck A., Greisler, Howard P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893
cites cdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893
container_end_page 663
container_issue 4
container_start_page 654
container_title World journal of surgery
container_volume 31
creator Ucuzian, Areck A.
Greisler, Howard P.
description Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts.
doi_str_mv 10.1007/s00268-006-0763-4
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70309172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1247171591</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRbK3-AC9aBL1FZ2c3u9mjih-VioeKHpfsZlZS0qRmLdJ_b0oDghdPM4fnfWd4GDvmcMkB9FUEQJUlACoBrUQid9iQS4EJChS7bAhCyW7nYsAOYpwDcK1A7bMB10KjUumQnU7q8Vv51Tbj56agKo6bML6uP8rmg2qKZTxkeyGvIh31c8Rm93evt4_J9OVhcns9TbzUiEluMHVUUJBZGhxqSZn2RfBowAuQ6BxRII-YgswLWTjpQDjhHWUhM2LELraty7b5XFH8sosyeqqqvKZmFa0GAYZr7MCzP-C8WbV195lFbozEDDdtfAv5tomxpWCXbbnI27XlYDfi7Fac7cTZjTgru8xJX7xyCyp-E72pDjjvgTz6vAptXvsy_nKZ0gbNhjNb7rusaP3_Zfv-NLu5ByEyFD9eHoS0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219942829</pqid></control><display><type>article</type><title>In Vitro Models of Angiogenesis</title><source>Springer Link</source><creator>Ucuzian, Areck A. ; Greisler, Howard P.</creator><creatorcontrib>Ucuzian, Areck A. ; Greisler, Howard P.</creatorcontrib><description>Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts.</description><identifier>ISSN: 0364-2313</identifier><identifier>EISSN: 1432-2323</identifier><identifier>DOI: 10.1007/s00268-006-0763-4</identifier><identifier>PMID: 17372665</identifier><identifier>CODEN: WJSUDI</identifier><language>eng</language><publisher>New York: Springer‐Verlag</publisher><subject>Angiogenesis Inhibitors - pharmacology ; Angiogenesis Model ; Animals ; Biological and medical sciences ; Fibroblast Growth Factor ; General aspects ; Growth Factor Delivery ; Humans ; Intercellular Signaling Peptides and Proteins - pharmacology ; Medical sciences ; Models, Biological ; Mural Cell ; Neovascularization, Pathologic - drug therapy ; Neovascularization, Pathologic - physiopathology ; Neovascularization, Physiologic - drug effects ; Neovascularization, Physiologic - physiology ; Tissue Engineering - methods ; Vascular Diseases - therapy ; Vascular Endothelial Growth Factor</subject><ispartof>World journal of surgery, 2007-04, Vol.31 (4), p.654-663</ispartof><rights>2007 The Author(s) under exclusive licence to Société Internationale de Chirurgie</rights><rights>2007 INIST-CNRS</rights><rights>Société Internationale de Chirurgie 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</citedby><cites>FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18679295$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17372665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ucuzian, Areck A.</creatorcontrib><creatorcontrib>Greisler, Howard P.</creatorcontrib><title>In Vitro Models of Angiogenesis</title><title>World journal of surgery</title><addtitle>World J Surg</addtitle><description>Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts.</description><subject>Angiogenesis Inhibitors - pharmacology</subject><subject>Angiogenesis Model</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Fibroblast Growth Factor</subject><subject>General aspects</subject><subject>Growth Factor Delivery</subject><subject>Humans</subject><subject>Intercellular Signaling Peptides and Proteins - pharmacology</subject><subject>Medical sciences</subject><subject>Models, Biological</subject><subject>Mural Cell</subject><subject>Neovascularization, Pathologic - drug therapy</subject><subject>Neovascularization, Pathologic - physiopathology</subject><subject>Neovascularization, Physiologic - drug effects</subject><subject>Neovascularization, Physiologic - physiology</subject><subject>Tissue Engineering - methods</subject><subject>Vascular Diseases - therapy</subject><subject>Vascular Endothelial Growth Factor</subject><issn>0364-2313</issn><issn>1432-2323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkE1Lw0AQhhdRbK3-AC9aBL1FZ2c3u9mjih-VioeKHpfsZlZS0qRmLdJ_b0oDghdPM4fnfWd4GDvmcMkB9FUEQJUlACoBrUQid9iQS4EJChS7bAhCyW7nYsAOYpwDcK1A7bMB10KjUumQnU7q8Vv51Tbj56agKo6bML6uP8rmg2qKZTxkeyGvIh31c8Rm93evt4_J9OVhcns9TbzUiEluMHVUUJBZGhxqSZn2RfBowAuQ6BxRII-YgswLWTjpQDjhHWUhM2LELraty7b5XFH8sosyeqqqvKZmFa0GAYZr7MCzP-C8WbV195lFbozEDDdtfAv5tomxpWCXbbnI27XlYDfi7Fac7cTZjTgru8xJX7xyCyp-E72pDjjvgTz6vAptXvsy_nKZ0gbNhjNb7rusaP3_Zfv-NLu5ByEyFD9eHoS0</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Ucuzian, Areck A.</creator><creator>Greisler, Howard P.</creator><general>Springer‐Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>200704</creationdate><title>In Vitro Models of Angiogenesis</title><author>Ucuzian, Areck A. ; Greisler, Howard P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Angiogenesis Inhibitors - pharmacology</topic><topic>Angiogenesis Model</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Fibroblast Growth Factor</topic><topic>General aspects</topic><topic>Growth Factor Delivery</topic><topic>Humans</topic><topic>Intercellular Signaling Peptides and Proteins - pharmacology</topic><topic>Medical sciences</topic><topic>Models, Biological</topic><topic>Mural Cell</topic><topic>Neovascularization, Pathologic - drug therapy</topic><topic>Neovascularization, Pathologic - physiopathology</topic><topic>Neovascularization, Physiologic - drug effects</topic><topic>Neovascularization, Physiologic - physiology</topic><topic>Tissue Engineering - methods</topic><topic>Vascular Diseases - therapy</topic><topic>Vascular Endothelial Growth Factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ucuzian, Areck A.</creatorcontrib><creatorcontrib>Greisler, Howard P.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ucuzian, Areck A.</au><au>Greisler, Howard P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vitro Models of Angiogenesis</atitle><jtitle>World journal of surgery</jtitle><addtitle>World J Surg</addtitle><date>2007-04</date><risdate>2007</risdate><volume>31</volume><issue>4</issue><spage>654</spage><epage>663</epage><pages>654-663</pages><issn>0364-2313</issn><eissn>1432-2323</eissn><coden>WJSUDI</coden><abstract>Neovascularization can be categorized into two general processes: vasculogenesis and angiogenesis. Angiogenesis is the formation of new capillaries from pre‐existing vessels, requiring growth factor driven recruitment, migration, proliferation, and differentiation of endothelial cells (ECs). Complex cell–cell and cell‐extracellular matrix (ECM) interactions contribute to this process, leading finally to a network of tube‐like formations of endothelial cells supported by surrounding mural cells. The study of angiogenesis has broad clinical implications in the fields of peripheral and coronary vascular disease, oncology, hematology, wound healing, dermatology, and ophthalmology, among others. As such, novel, clinically relevant models of angiogenesis in vitro are crucial to the understanding of angiogenic processes. We highlight some of the advances made in the development of these models, and discuss the importance of incorporating the three‐dimensional cell‐matrix and EC–mural cell interactions into these in vitro assays of angiogenesis. This review also discusses our own 3‐D angiogenesis assay and some of the in vitro results from our lab as they relate to therapeutic neovascularization and tissue engineering of vascular grafts.</abstract><cop>New York</cop><pub>Springer‐Verlag</pub><pmid>17372665</pmid><doi>10.1007/s00268-006-0763-4</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0364-2313
ispartof World journal of surgery, 2007-04, Vol.31 (4), p.654-663
issn 0364-2313
1432-2323
language eng
recordid cdi_proquest_miscellaneous_70309172
source Springer Link
subjects Angiogenesis Inhibitors - pharmacology
Angiogenesis Model
Animals
Biological and medical sciences
Fibroblast Growth Factor
General aspects
Growth Factor Delivery
Humans
Intercellular Signaling Peptides and Proteins - pharmacology
Medical sciences
Models, Biological
Mural Cell
Neovascularization, Pathologic - drug therapy
Neovascularization, Pathologic - physiopathology
Neovascularization, Physiologic - drug effects
Neovascularization, Physiologic - physiology
Tissue Engineering - methods
Vascular Diseases - therapy
Vascular Endothelial Growth Factor
title In Vitro Models of Angiogenesis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T19%3A57%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vitro%20Models%20of%20Angiogenesis&rft.jtitle=World%20journal%20of%20surgery&rft.au=Ucuzian,%20Areck%20A.&rft.date=2007-04&rft.volume=31&rft.issue=4&rft.spage=654&rft.epage=663&rft.pages=654-663&rft.issn=0364-2313&rft.eissn=1432-2323&rft.coden=WJSUDI&rft_id=info:doi/10.1007/s00268-006-0763-4&rft_dat=%3Cproquest_cross%3E1247171591%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4722-a925bedef485fb274e87cdfc290c3042bbeefec22504ad4db4b03b3cbe8f893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=219942829&rft_id=info:pmid/17372665&rfr_iscdi=true